Medical Representatives’ Training Programme 2022
The HKAPI Medical Representatives’ Training Programme 2022 will be commenced on 7 April 2022 (Thu), the programme information, the schedule and the course rules are as follows Course Period: 7 […]
The HKAPI Medical Representatives’ Training Programme 2022 will be commenced on 7 April 2022 (Thu), the programme information, the schedule and the course rules are as follows Course Period: 7 […]
Dear member, Following the Cheif Executive's presentation of his first Policy Address on 19 October 2022, the HKAPI is organizing the second CEO meeting of this term (2022 – 2024) […]
Following the update of the HKAPI Code of Practice in October 2022, the Ethics & Compliance Working Group is organizing the Train-the-Trainers Workshop to provide a deep dive into the […]
The Regulatory Working Group will kick off an all-year-long survey on Regulatory Intelligence to learn from members the latest practices of local & overseas regulators that may bring systemic impact […]
In this seminar, representatives from Linklaters will cover key enforcement trends in the past year, as well as provide you with insights into proceedings in the Competition Tribunal. We will also discuss how this is relevant to the pharmaceutical industry in Hong Kong and practical tips to ensure full compliance with competition law.
We are excited to announce the upcoming 55th Annual General Meeting (AGM) of the Hong Kong Association of the Pharmaceutical Industry, which will be held on 22 March 2023.
Dear HKAPI Members, We are delighted to invite you to our Primary Healthcare Sharing Session, organized by the HKAPI Primary Healthcare Task Force. The event is scheduled to take place […]
Dear Members, We are delighted to invite you to participate in the HKAPI Market Access Workshop 2023, designed to provide valuable insights and essential skills for individuals new to the […]
Dear Full and Affiliate Members: We are pleased to invite you to the 56th Annual General Meeting (AGM) of the Hong Kong Association of the Pharmaceutical Industry (HKAPI) to be […]
The HKAPI Drug Enlistment & Reimbursement in HA Project Team recently met with the Hospital Authority (HA) to address outstanding questions from our members regarding the new drug enlistment mechanism. We are pleased to share the outcomes of this important discussion with all members.
Dear Members, We are pleased to invite you to an Online Sharing Session conducted by the HKAPI Chronic Disease Co-Care Scheme & Community Drug Formulary Project Team (CDCC & CDF […]
We are pleased to announce an interactive workshop on value-based healthcare, supported by one of our Catalyst members, Vista Health. Vista Health will share insights on the application of value-based […]